Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for CorMedix (CRMD) over the last 14 years, with Q2 2025 value amounting to $67.9 million.

  • CorMedix's Shares Outstanding (Weighted Average) rose 1788.71% to $67.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $67.9 million, marking a year-over-year increase of 1788.71%. This contributed to the annual value of $58.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that CorMedix reported Shares Outstanding (Weighted Average) of $67.9 million as of Q2 2025, which was up 1788.71% from $65.2 million recorded in Q1 2025.
  • CorMedix's 5-year Shares Outstanding (Weighted Average) high stood at $67.9 million for Q2 2025, and its period low was $36.3 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $44.1 million (2023), whereas its average is $48.3 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 4567.31% in 2021, then soared by 401.75% in 2024.
  • CorMedix's Shares Outstanding (Weighted Average) (Quarter) stood at $37.7 million in 2021, then increased by 6.92% to $40.3 million in 2022, then surged by 40.42% to $56.6 million in 2023, then increased by 4.1% to $58.9 million in 2024, then grew by 15.38% to $67.9 million in 2025.
  • Its last three reported values are $67.9 million in Q2 2025, $65.2 million for Q1 2025, and $58.9 million during Q4 2024.